INVESTOR AB - Q1 2023 holdings

$3.18 Billion is the total value of INVESTOR AB's 7 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 40.0% .

 Value Shares↓ Weighting
NDAQ  NASDAQ Inc.$3,180,833,229
-10.9%
58,182,4260.0%99.92%
-0.1%
TIGO NewMillicom Int. Cellular$944,00050,000
+100.0%
0.03%
MU BuyMicron Technology Inc.$799,373
+93.9%
13,250
+60.6%
0.02%
+108.3%
SWK  Stanley Black & Decker Inc.$459,135
+7.2%
5,7000.0%0.01%
+16.7%
NEON NewNeonode Inc.$302,6803,774
+100.0%
0.01%
 WeWork Inc.cl a$177,168
-45.5%
227,1390.0%0.01%
-33.3%
 Agile Therapeutics Inc.$19,657
-2.6%
87,7540.0%0.00%0.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NASDAQ OMX GROUP INC42Q3 2023100.0%
AGILE THERAPEUTICS INC32Q1 20223.5%
CHINACACHE INTL HLDG LTD21Q2 20187.3%
MATTERSIGHT CORP21Q2 20182.0%
CORCEPT THERAPEUTICS INC18Q3 20171.8%
TANGOE INC16Q1 20174.0%
NEURONETICS INC11Q4 20203.3%
CONSTANT CONTACT INC11Q4 20150.7%
CARLYLE GROUP LP11Q1 20180.2%
STANLEY BLACK & DECKER, INC.9Q3 20230.0%

View INVESTOR AB's complete holdings history.

Latest significant ownerships (13-D/G)
INVESTOR AB Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ABB LTDJune 27, 2022265,385,14214.0%
ChinaCache International Holdings Ltd.Sold outFebruary 14, 201900.0%
AGILE THERAPEUTICS INCFebruary 17, 20153,510,18918.9%
GREENWAY MEDICAL TECHNOLOGIES INCSold outFebruary 14, 201400.0%
TANGOE INCFebruary 14, 20141,440,0003.8%
Mattersight CorpSold outMay 10, 201200.0%
ISTA PHARMACEUTICALS INCFebruary 14, 20111,258,0753.8%
ACHILLION PHARMACEUTICALS INCFebruary 11, 20111,980,1293.4%
ChinaCache International Holdings Ltd.February 11, 201155,885,47514.5%
ISTA PHARMACEUTICALS INCApril 08, 20052,001,8967.8%

View INVESTOR AB's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
SC 13D/A2023-11-06
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
SC 13D/A2022-12-16
13F-HR2022-11-14
SC 13D/A2022-08-26
13F-HR2022-08-15

View INVESTOR AB's complete filings history.

Compare quarters

Export INVESTOR AB's holdings